Timothy Ming-Hun Wan

651 total citations
16 papers, 511 citations indexed

About

Timothy Ming-Hun Wan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Timothy Ming-Hun Wan has authored 16 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Timothy Ming-Hun Wan's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (5 papers). Timothy Ming-Hun Wan is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (5 papers). Timothy Ming-Hun Wan collaborates with scholars based in Hong Kong and China. Timothy Ming-Hun Wan's co-authors include Lui Ng, Ariel Ka-Man Chow, Thomas Yau, Oswens Siu‐Hung Lo, Jensen Tung‐Chung Poon, CC Foo, Wai‐Lun Law, Alvin H.K. Cheung, Hung Sing Li and Roberta Pang and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Oncotarget.

In The Last Decade

Timothy Ming-Hun Wan

16 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Ming-Hun Wan Hong Kong 12 296 224 192 58 49 16 511
Nina Waldburger Germany 13 201 0.7× 119 0.5× 149 0.8× 100 1.7× 34 0.7× 19 456
Thomas Niemietz Germany 7 130 0.4× 236 1.1× 260 1.4× 15 0.3× 31 0.6× 7 469
Wenjie Dong China 16 385 1.3× 183 0.8× 113 0.6× 20 0.3× 37 0.8× 32 628
Giuditta Viticchiè United Kingdom 8 400 1.4× 276 1.2× 120 0.6× 29 0.5× 17 0.3× 10 590
Sander P.J. Joosten Netherlands 10 288 1.0× 101 0.5× 236 1.2× 36 0.6× 51 1.0× 12 481
Warren Shih Canada 9 351 1.2× 132 0.6× 269 1.4× 54 0.9× 65 1.3× 9 617
Torill Høiby United States 6 318 1.1× 100 0.4× 255 1.3× 15 0.3× 45 0.9× 8 658
Eric Sceusi United States 6 424 1.4× 227 1.0× 419 2.2× 20 0.3× 29 0.6× 10 704
Minghui Zhang China 12 321 1.1× 173 0.8× 132 0.7× 24 0.4× 38 0.8× 19 494

Countries citing papers authored by Timothy Ming-Hun Wan

Since Specialization
Citations

This map shows the geographic impact of Timothy Ming-Hun Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Ming-Hun Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Ming-Hun Wan more than expected).

Fields of papers citing papers by Timothy Ming-Hun Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Ming-Hun Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Ming-Hun Wan. The network helps show where Timothy Ming-Hun Wan may publish in the future.

Co-authorship network of co-authors of Timothy Ming-Hun Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Ming-Hun Wan. A scholar is included among the top collaborators of Timothy Ming-Hun Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Ming-Hun Wan. Timothy Ming-Hun Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wan, Timothy Ming-Hun, et al.. (2023). Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe. International Journal of Molecular Sciences. 24(19). 14646–14646. 4 indexed citations
2.
Foo, CC, Oswens Siu‐Hung Lo, Timothy Ming-Hun Wan, et al.. (2022). MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer. BMC Cancer. 22(1). 351–351. 4 indexed citations
3.
Ng, Lui, Timothy Ming-Hun Wan, Zheng Huang, et al.. (2022). High Levels of Tumor miR-187-3p—A Potential Tumor-Suppressor microRNA—Are Correlated with Poor Prognosis in Colorectal Cancer. Cells. 11(15). 2421–2421. 4 indexed citations
4.
Ng, Lui, Xue Li, Timothy Ming-Hun Wan, et al.. (2021). Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells. European Journal of Surgical Oncology. 48(1). 245–252. 5 indexed citations
5.
Wan, Timothy Ming-Hun, Xue Li, Oswens Siu‐Hung Lo, et al.. (2020). Small RNA Profiling of piRNAs in Colorectal Cancer Identifies Consistent Overexpression of piR-24000 That Correlates Clinically with an Aggressive Disease Phenotype. Cancers. 12(1). 188–188. 30 indexed citations
6.
Ng, Lui, Ariel Ka-Man Chow, Thomas Yau, et al.. (2018). Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway. BMC Cancer. 18(1). 621–621. 14 indexed citations
7.
Ng, Lui, Timothy Ming-Hun Wan, Ariel Ka-Man Chow, et al.. (2017). Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer. Oncotarget. 8(16). 27393–27400. 54 indexed citations
8.
Ng, Lui, Ariel Ka-Man Chow, Timothy Ming-Hun Wan, et al.. (2017). Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer. Oncotarget. 8(16). 26858–26870. 33 indexed citations
9.
Cheung, Alvin H.K., Lui Ng, Sunny H. Wong, et al.. (2017). Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis. International Journal of Molecular Sciences. 18(6). 1106–1106. 14 indexed citations
10.
Ng, Lui, Timothy Ming-Hun Wan, Ariel Ka-Man Chow, et al.. (2015). Post-Operative Plasma Osteopontin Predicts Distant Metastasis in Human Colorectal Cancer. PLoS ONE. 10(5). e0126219–e0126219. 31 indexed citations
11.
Ng, Lui, Timothy Ming-Hun Wan, Ariel Ka-Man Chow, et al.. (2015). Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer. Stem Cells International. 2015. 1–8. 35 indexed citations
12.
Cheung, Alvin H.K., Timothy Ming-Hun Wan, Lui Ng, et al.. (2014). Prognostic Significance of CD26 in Patients with Colorectal Cancer. PLoS ONE. 9(5). e98582–e98582. 64 indexed citations
13.
Wan, Timothy Ming-Hun, et al.. (2014). Plasma Bmi1 mRNA as a potential prognostic biomarker for distant metastasis in colorectal cancer patients. Molecular and Clinical Oncology. 2(5). 817–820. 17 indexed citations
14.
Wan, Timothy Ming-Hun, Lui Ng, Ariel Ka-Man Chow, et al.. (2014). The Clinicopathological Significance of miR-133a in Colorectal Cancer. Disease Markers. 2014. 1–8. 21 indexed citations
15.
Chow, Ariel Ka-Man, et al.. (2013). The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance. PLoS ONE. 8(11). e78675–e78675. 106 indexed citations
16.
Ho, David, Zhen Yang, Yi Kang, et al.. (2012). Gene Expression Profiling of Liver Cancer Stem Cells by RNA-Sequencing. PLoS ONE. 7(5). e37159–e37159. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026